This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Redchenko, I. V.
Right arrow Articles by Rickinson, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Redchenko, I. V.
Right arrow Articles by Rickinson, A. B.

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 334-342, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Accessing Epstein-Barr Virus-Specific T-Cell Memory with Peptide-Loaded Dendritic Cells

I. V. Redchenko and A. B. Rickinson*

CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TA United Kingdom

Received 20 July 1998/Accepted 17 September 1998

The conventional means of studying Epstein-Barr virus (EBV)-induced cytotoxic T-lymphocyte (CTL) memory, by in vitro stimulation with the latently infected autologous lymphoblastoid cell line (LCL), has important limitations. First, it gives no information on memory to lytic cycle antigens; second, it preferentially amplifies the dominant components of latent antigen-specific memory at the expense of key subdominant reactivities. Here we describe an alternative approach, based on in vitro stimulation with epitope peptide-loaded dendritic cells (DCs), which allows one to probe the CTL repertoire for any individual reactivity of choice; this method proved significantly more efficient than stimulation with peptide alone. Using this approach we first show that reactivities to the immunodominant and subdominant lytic cycle epitopes identified by T cells during primary EBV infection are regularly detectable in the CTL memory of virus carriers; this implies that in such carriers chronic virus replication remains under direct T-cell control. We further show that subdominant latent cycle reactivities to epitopes in the latent membrane protein LMP2, though rarely undetectable in LCL-stimulated populations, can be reactivated by DC stimulation and selectively expanded as polyclonal CTL lines; the adoptive transfer of such preparations may be of value in targeting certain EBV-positive malignancies.

* Corresponding author. Mailing address: CRC Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TA United Kingdom. Phone: 121-414-4492. Fax: 121-414-4486. E-mail: Williamsd{at}cancer.bham.ac.uk.

Journal of Virology, January 1999, p. 334-342, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Fogg, M. H., Garry, D., Awad, A., Wang, F., Kaur, A. (2006). The BZLF1 Homolog of an Epstein-Barr-Related {gamma}-Herpesvirus Is a Frequent Target of the CTL Response in Persistently Infected Rhesus Macaques. J. Immunol. 176: 3391-3401 [Abstract] [Full Text]  
  • Taylor, G. S., Haigh, T. A., Gudgeon, N. H., Phelps, R. J., Lee, S. P., Steven, N. M., Rickinson, A. B. (2004). Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma. J. Virol. 78: 768-778 [Abstract] [Full Text]  
  • Santodonato, L., D'Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L., Paola Perrone, M., Andreotti, M., Belardelli, F., Ferrantini, M. (2003). Monocyte-Derived Dendritic Cells Generated After a Short-Term Culture with IFN-{alpha} and Granulocyte-Macrophage Colony-Stimulating Factor Stimulate a Potent Epstein-Barr Virus-Specific CD8+ T Cell Response. J. Immunol. 170: 5195-5202 [Abstract] [Full Text]  
  • Kuzushima, K., Hayashi, N., Kudoh, A., Akatsuka, Y., Tsujimura, K., Morishima, Y., Tsurumi, T. (2003). Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 101: 1460-1468 [Abstract] [Full Text]  
  • Wang, Q. J., Huang, X.-L., Rappocciolo, G., Jenkins, F. J., Hildebrand, W. H., Fan, Z., Thomas, E. K., Rinaldo, C. R. Jr (2002). Identification of an HLA A*0201-restricted CD8+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 99: 3360-3366 [Abstract] [Full Text]  
  • Wilson, A. D., Morgan, A. J. (2002). Primary Immune Responses by Cord Blood CD4+ T Cells and NK Cells Inhibit Epstein-Barr Virus B-Cell Transformation In Vitro. J. Virol. 76: 5071-5081 [Abstract] [Full Text]  
  • Chapman, A. L. N., Rickinson, A. B., Thomas, W. A., Jarrett, R. F., Crocker, J., Lee, S. P. (2001). Epstein-Barr Virus-specific Cytotoxic T Lymphocyte Responses in the Blood and Tumor Site of Hodgkin's Disease Patients: Implications for a T-cell-based Therapy. Cancer Res. 61: 6219-6226 [Abstract] [Full Text]  
  • Dhodapkar, M. V., Young, J. W., Chapman, P. B., Cox, W. I., Fonteneau, J. F., Amigorena, S., Houghton, A. N., Steinman, R. M., Bhardwaj, N. (2000). Paucity of Functional T-Cell Memory to Melanoma Antigens in Healthy Donors and Melanoma Patients. Clin. Cancer Res. 6: 4831-4838 [Abstract] [Full Text]  
  • Ibisch, C., Saulquin, X., Gallot, G., Vivien, R., Ferrand, C., Tiberghien, P., Houssaint, E., Vie, H. (2000). The T Cell Repertoire Selected In Vitro Against EBV: Diversity, Specificity, and Improved Purification Through Early IL-2 Receptor {alpha}-Chain (CD25)-Positive Selection. J. Immunol. 164: 4924-4932 [Abstract] [Full Text]  
  • Caldwell, R. G., Brown, R. C., Longnecker, R. (2000). Epstein-Barr Virus LMP2A-Induced B-Cell Survival in Two Unique Classes of E{micro}LMP2A Transgenic Mice. J. Virol. 74: 1101-1113 [Abstract] [Full Text]  
  • Ranieri, E., Herr, W., Gambotto, A., Olson, W., Rowe, D., Robbins, P. D., Kierstead, L. S., Watkins, S. C., Gesualdo, L., Storkus, W. J. (1999). Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination. J. Virol. 73: 10416-10425 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»